These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 109416)

  • 1. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT; Daly JJ; Irwin RJ; Prout GR
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical and systemic chemotherapy of murine bladder cancer.
    Soloway MS
    Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
    [No Abstract]   [Full Text] [Related]  

  • 4. Nucleic acid synthesis in ladder tumors.
    Veenema RJ; Fingerhut B; Graff S
    Trans Am Assoc Genitourin Surg; 1970; 62():155-9. PubMed ID: 5492387
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of normal and cancerous rat bladder to antineoplastic agents.
    Bessman JD; Johnson RK; Goldin A
    Urology; 1975 Aug; 6(2):187-93. PubMed ID: 807008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of FANFT induced bladder tumours in rats by intravesical DNCB instillation.
    Johnson DK; Pontes JE; Izbicki R; Pierce JM
    Urol Res; 1980; 8(1):23-4. PubMed ID: 7368458
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS; Jordan AM; Murphy WM
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Wang CY; Hayashida S; Pamukcu AM; Bryan GT
    Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
    Nocks BN; Nieh PT; Prout GR
    J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis.
    Cohen SM; Arai M; Jacobs JB; Friedell GH
    Cancer Res; 1979 Apr; 39(4):1207-17. PubMed ID: 421204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
    Daskal Y; Soloway MS; DeFuria MD; Crooke ST
    Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
    Puchner PJ; Veenema RJ; Tomashefsky P; Pinzus T; Tannenbaum T
    Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of topical instillation of adriamycin in bladder tumors of rats fed with FANFT.
    Pontes JE; Izbicki R; Silberberg B; Baker L; Pierce JM
    Invest Urol; 1978 Jan; 15(4):278-9. PubMed ID: 627470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The morphologic effects of mitomycin C in mammalian urinary bladder.
    Murphy WM; Soloway MS; Crabtree WN
    Cancer; 1981 Jun; 47(11):2567-74. PubMed ID: 6790156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic effects of thio-TEPA on mammalian urothelium. Changes in abnormal cells.
    Murphy WM; Soloway MS; Lin CJ
    Acta Cytol; 1978; 22(6):550-4. PubMed ID: 104512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.